VLRX stock forecast
Our latest prediction for Valeritas Holdings, Inc.'s stock price was made on the Dec. 20, 2019 when the stock price was at 0.65$.
In the short term (2weeks), VLRX's stock price should outperform the market by 0.35%. During that period the price should oscillate between -15.42% and +26.49%.
In the medium term (3months), VLRX's stock price should underperform the market by -6.71%. During that period the price should oscillate between -48.56% and +73.36%.Get email alerts
About Valeritas Holdings, Inc.
Valeritas Holdings, Inc. is a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with diabetes. It offers products under the V-Go brand. V-Go Disposable Insulin Delivery Device, is used by patients with type 2 diabetes to maintain target blood glucose goals. The firm's single-use disposable V-Go device includes V-Go PreFill and V-Go Link. The company was founded by Leisa Swanson and Robert R. Gonnelli on May 9, 2014 and is headquartered in Bridgewater, NJ.
At the moment the company generates 29M USD in revenues.
On its last earning announcement, the company reported a profit of 0.88$ per share.
The book value per share is 0.11$
Three months stock forecastDec. 20, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|